MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
"Triple Helix" Innovation Model
4. Triple Helix _ Capture Strategies
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Industry: Research Triangle, North Carolina
*Bioscience Regional Clusters & HotSpots
*Industry: Northern California & Silicon Valley
Dynavax Technologies Corporation (NASDAQ:DVAX)*
Organization & Developments: Dynavax
Parents
Dynavax Technologies Corporation (NASDAQ:DVAX)*
Children
*DNA based therapeutics
*Organization & Developments: Dynavax (Archives 2016-2018)
2019: An Update On Dynavax_seekingalpha.com
2019: Dynavax axes immuno-oncology pipeline and 82 staff
2019: Dynavax Projects HEPLISAV-B Inflection In 2019, While CEO Eddie Gray Continues To Search For SD-101 Partners - Dynavax Technologies Corporation (NASDAQ:DVAX)
2019: Dynavax: Concentrating On Vaccines Could Stabilize The Investment_seekingalpha.com
2019: Dynavax: On Borrowed Time_seekingalpha.com
2019: Dynavax: On Troubled Waters_seekingalpha.com
2020: Dynavax: Ready To Return To Bullish
2020: Dynavax's Restructuring: A Work In Progress
2021: Diving Into Dynavax Technologies
2021: Dynavax And TLR Biology: Long-Delayed But Outstanding Success
2021: Dynavax Technologies: A Surprising COVID-19 Play
2021: Dynavax Technologies: An Emerging Covid19 Dynamo
2022: Dynavax Technologies Corporation 2022 Q3 - Results - Earnings Call Presentation_ seekingalpha.com
2022: Dynavax Technologies: Stellar Results, But Little Respect_ seekingalpha.com
2023: Dynavax Technologies: The Covid Lifeline Expires_ seekingalpha.com
2023: Dynavax: Analyzing Mixed Signals, A Closer Look At Heplisav-B
2024: Dynavax Announces $100 Million Accelerated Share Repurchase Program
2024: Dynavax Launches $100M Share Buyback Deal with Goldman Sachs, Signals Strong Confidence
2024: Dynavax Technologies Corporation 2023 Q4 - Results - Earnings Call Presentation
2024: Dynavax Technologies: A Two Trick Pony Operating With A Single Trick
2024: Dynavax Technologies: Still A Believer
2024: Dynavax Technologies: Still A Solid Pick For 2024_ seekingalpha.com
2024: Dynavax Technologies: What The Stock Buyback Means, What It Doesn't
2024: Dynavax: Holding Firm Despite Its Missing Cash Cow
2024: Wall Street Analysts Predict an 88.32% Upside in Dynavax Technologies (DVAX): Here's What You Should Know
2025: Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy
2025: Dynavax Technologies: A Post-Earnings Assessment With Growing Market Share
2025: Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good
2025: Dynavax Technologies: Time To Refocus On Former Cash Cow CpG1018
2025: Dynavax’s SWOT analysis: hepatitis B vaccine maker’s stock poised for growth
Jumps
*Key People: Dynavax
Finance & Acquisitions: Dynavax